EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis

Gwenaëlle De Clifford-Faugère, Hermine Lore Nguena Nguefack, Manon Choinière, M Gabrielle Pagé iD, Lucie Blais, Line Guénette iD, Marc Dorais, Anaïs Lacasse

International Journal of Environmental Research and Public Health · 01.08.2023 · 20 (15) · 6493

DOI: 10.3390/ijerph20156493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 01.08.2023. Verfasst von Gwenaëlle De Clifford-Faugère und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC J9X 5E4, Canada. Hauptthemen laut MEDLINE: Chronic Pain, COVID-19, Prescription Drugs, Opioid-Related Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quebec Network on Drug Research, Quebec Pain Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Canada, a state of health emergency was declared in May 2020 as a result of the COVID-19 pandemic. This study aimed to assess trends in the use of prescription medication for pain management by people living with chronic pain before and during the first wave of the pandemic.

Methods

Participants (n = 177) were adults reporting chronic pain who had completed a web-based questionnaire in 2019 and for whom complete longitudinal private and public insurance prescription claims were available. The monthly prevalence of medication use for nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and prescribed cannabinoids was assessed. An interrupted time series analysis was then performed to evaluate if the COVID-19 pandemic had had an impact on trends in pain medication use.

Results

The beginning of the first wave of the pandemic was associated with the onset of a downward trend in opioid use (p < 0.05); no such association was found regarding NSAIDs. However, point prevalence of opioid use at the beginning (Nov. 2019) and at the end (Mai 2020) of the study period remained somewhat stable (17.0% vs. 16.4%). Regarding prescribed cannabinoids, a gradual increase in use was observed over the entire study period independently from the impact of the first wave of the pandemic (15.3% vs. 22.6%, p < 0.05).

Conclusion

While the occurrence of the first wave did have an impact on opioid use among people living with chronic pain, access to and use of opioids appear to have returned to normal before the end of the first wave of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainCOVID-19Prescription DrugsOpioid-Related DisordersAdultHumansAnalgesics, OpioidPandemicsQuebecInterrupted Time Series AnalysisAnti-Inflammatory Agents, Non-SteroidalCanadaPrescriptions

Stichwörter der Autor:innen

analgesicscannabinoidsdrug claimsnonsteroidal anti-inflammatory drugsopioidspain management

Substanzen

Analgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalPrescription Drugs

Autor:innen und Institutionen

  • Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, QC J9X 5E4, Canada.
  • Research Center of the Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
  • Department of Anesthesiology and Pain Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Faculty of Pharmacy, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Faculty of Pharmacy, Université Laval, Québec, QC G1V 0A6, Canada.
  • Axe Santé des Populations et Pratiques Optimales en Santé, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.

ORCID-Profile: M Gabrielle Pagé, Line Guénette

Förderung

  • Quebec Network on Drug Research
  • Quebec Pain Research Network

Zitieren

APA

De Clifford-Faugère, G., Nguena Nguefack, H. L., Choinière, M., Pagé, M. G., Blais, L., Guénette, L., Dorais, M., & Lacasse, A. (2023). Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis. International Journal of Environmental Research and Public Health, 20(15), 6493. https://doi.org/10.3390/ijerph20156493

Vancouver

De Clifford-Faugère G, Nguena Nguefack HL, Choinière M, Pagé MG, Blais L, Guénette L, et al. Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis. International Journal of Environmental Research and Public Health. 2023;20(15):6493. doi:10.3390/ijerph20156493

BibTeX
@article{DeCliffordFaugre2023,
  author = {De Clifford-Faugère, Gwenaëlle and Nguena Nguefack, Hermine Lore and Choinière, Manon and Pagé, M Gabrielle and Blais, Lucie and Guénette, Line and Dorais, Marc and Lacasse, Anaïs},
  title = {Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2023},
  volume = {20},
  number = {15},
  pages = {6493},
  doi = {10.3390/ijerph20156493}
}
Kostenlos starten →